Send to

Choose Destination
J Foot Ankle Surg. 2018 Nov - Dec;57(6):1225-1229. doi: 10.1053/j.jfas.2018.03.006. Epub 2018 May 18.

Achilles Tendon Augmented Repair Using Human Acellular Dermal Matrix: A Case Series.

Author information

Adjunct Faculty and Director, Wound Care Research, Kent State University College of Podiatric Medicine, Independence, OH; Medical Director, Wound Care Center, University Hospitals Ahuja Medical Center, Beachwood, OH. Electronic address:
Scientific Writer, Scientific Affairs, LifeNet Health, Virginia Beach, VA.
Global Senior Director, Scientific Affairs, LifeNet Health, Virginia Beach, VA.


Achilles tendon ruptures are common in the general population, especially among members of the older demographic occasionally active in sports. Operative treatments provide a lower incidence of rerupture than do nonoperative treatments, although surgical complications remain a concern. The use of a human acellular dermal matrix to augment Achilles tendon repair might reduce the incidence of complications. In the present case series, we describe the outcomes of 9 patients who underwent Achilles tendon repair with acellular dermal matrix augmentation. Functional outcomes were evaluated using the Foot Function Index-Revised long form, and the clinical results were recorded. After a mean average follow-up period of 14.4 (range 12.0 to 20.0) months, the mean Foot Function Index-Revised long form score was 33.0% ± 4.2%. No cases of rerupture or complications that required additional treatment occurred during the observation period. The outcomes we have presented support further evaluation beyond this case series for using a human acellular dermal matrix to augment Achilles tendon repairs.


Achilles tendon; ArthroFlex(®); acellular dermal matrix; allograft; augment; rupture; tear

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center